
Knowledge regarding how best to treat patients struggling with opioid addiction is constantly advancing. Now comes news that the long-acting buprenorphine formulation BUP-XR, a monthly extended release injection, may be a valuable treatment for opioid use disorders (OUD). Here’s a closer look at the research, as published late last month in The Lancet. About the…